The results demonstrated that this enhanced SDT strategy could induce ICD to improve the immunosuppressive microenvironment, thus boosting anti-programmed cell death-ligand 1 (PDL-1) therapy for colorectal cancer (Wan et al., 2021). The gene discussed is CD274; the disease is colorectal cancer.